Thinking of joining a study?

Register your interest

NCT05131074 | Enrolling by invitation | Hypertension


Collabree: A Remote Intervention to Improve the Regularity of Medication Intake
Sponsor:

Anjali Raja Beharalle

Information provided by (Responsible Party):

Anjali Raja Beharalle

Brief Summary:

This is a clinical study to improve the regularity of medication intake for high blood pressure. Adult women and men who are over 50 years old, who have received a prescription drug for high blood pressure from MediService, and who have to take at least 4 tablets per day (of which at least 1 dose of medication per day is for high blood pressure) can participate in this study. The investigators intend to examine whether Collabree, a mobile phone application, is effective in supporting patients with hypertension to more successfully following their therapy plan in order to improve the regularity of medication intake. The study includes a 90-day intervention phase and a 90-day follow-up. The study does not require any therapy adjustments and no visits to a study center are necessary. The participants conduct the study independently at home. Participants will also fill out questionnaires. Participants are randomly assigned to one of 3 groups in a ratio of 1: 1: 1. Two of these groups will receive the Collabree mobile phone application.

Condition or disease

Hypertension

Medication Adherence

Intervention/treatment

Collabree Mobile Phone Application Medication Adherence Booster

Collabree Mobile Phone Application Medication Adherence Booster (simplified version)

Phase

Not Applicable

Study Type : Interventional
Estimated Enrollment : 180 participants
Masking : None (Open Label)
Primary Purpose : Prevention
Official Title : Collabree: A Targeted Behavioral Economics-based Remote Intervention to Improve Medication Adherence in Patients With Hypertension
Actual Study Start Date : March 10, 2022
Estimated Primary Completion Date : August 2024
Estimated Study Completion Date : November 2024
Arm Intervention/treatment

Experimental: Intervention Group A

Patients receive the Collabree mobile phone application with a specific set of functions.

Experimental: Intervention Group B

Patients receive the Collabree mobile phone application with a specific set of functions.

No Intervention: Control Group

Patients will not receive the Collabree application.

Ages Eligible for Study: 50 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Criteria
Inclusion Criteria
  • Informed consent as documented by signature.
  • Over 50 years of age on date of randomization.
  • Patient received prescription medicine against hypertension by post from MediService.
  • Prescribed a therapy against hypertension consisting of 4 or more tablets taken per day. At least 1 dose of medication per day must be against hypertension.
  • Participant administers their own medications.
  • Participant owns a smartphone with a data plan or constant internet access during the study reporting events and at home to use the application.
  • Minimal required smartphone operating system is iOS 12 and Android 8 (Oreo).
  • Adequate communication in German or Swiss-German (all study documentation will only be set to the German language).
Exclusion Criteria
  • Inability to operate a mobile phone and the Collabree application.
  • Inability to follow the procedures of the study, e.g., due to language problems, psychological disorders, dementia, etc.
  • Enrollment of the Sponsor-Investigator, their family members, employees, and other dependent persons.
  • Participation in another interventional clinical trial.

Collabree: A Remote Intervention to Improve the Regularity of Medication Intake

Location Details


Please Choose a site



Collabree: A Remote Intervention to Improve the Regularity of Medication Intake

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Switzerland,

Collabree AG

Zürich, Switzerland, 8002

Loading...